SONOVA HOLDING (OTCMKTS:SONVY) Given Consensus Rating of “Reduce” by Brokerages

SONOVA HOLDING (OTCMKTS:SONVY) has received a consensus recommendation of “Reduce” from the nine brokerages that are covering the firm, MarketBeat Ratings reports. Four analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and one has issued a strong buy recommendation on the company.

A number of research firms have commented on SONVY. BNP Paribas downgraded SONOVA from a “strong-buy” rating to a “strong sell” rating in a report on Wednesday, June 11th. Kepler Capital Markets raised SONOVA from a “strong sell” rating to a “hold” rating in a research report on Friday, June 6th. Barclays cut SONOVA from a “hold” rating to a “strong sell” rating in a research note on Friday, June 20th. HSBC lowered shares of SONOVA from a “buy” rating to a “hold” rating in a research note on Wednesday, May 21st. Finally, Hsbc Global Res downgraded shares of SONOVA from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 21st.

SONOVA Stock Performance

Shares of SONVY stock opened at $60.02 on Monday. The company has a quick ratio of 0.96, a current ratio of 1.27 and a debt-to-equity ratio of 0.45. SONOVA has a one year low of $52.83 and a one year high of $77.56. The company’s 50-day simple moving average is $57.41 and its 200-day simple moving average is $59.91.

SONOVA Increases Dividend

The firm also recently announced a dividend, which was paid on Wednesday, July 2nd. Shareholders of record on Tuesday, June 17th were issued a $0.6243 dividend. This is an increase from SONOVA’s previous dividend of $0.57. This represents a yield of 99.0%. The ex-dividend date of this dividend was Monday, June 16th.

About SONOVA

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.